| Issue Date | Title | Author(s) |
| Sep-2022 | Discovery of Azo-Aminopyrimidines as Novel and Potent Chitinase Of Chi-h Inhibitors via Structure-Based Virtual Screening and Rational Lead Optimization | Dong, Lili; Shen, Shengqiang; Jiang, Xi; Liu, Yaxin; Li, Jingjing; Chen, Wei; Wang, Yizhen; Shi, Jiakun; Liu, Jiaxin; Ma, Shujie; Zhang, Lihui; Dong, Jingao; Yang, Qing |
| 2018 | Dorzagliatin monotherapy in Chinese patients with type 2 diabetes: a dose-ranging, randomised, double-blind, placebo-controlled, phase 2 study | Zhu, Dalong; Gan, Shenglian; Liu, Yu; Ma, Jianhua; Dong, Xiaolin; Song, Weihong; Zeng, Jiao'e; Wang, Guixia; Zhao, Wenjuan; Zhang, Qiu; Li, Yukun; Fang, Hui; Lv, Xiaofeng; Shi, Yongquan; Tian, Haoming; Ji, Linong; Gao, Xin; Zhang, Lihui; Bao, Yuqian; Lei, Minxiang; Li, Ling; Zeng, Longyi; Li, Xiaoying; Hou, Xinghua; Zhao, Yu; Hu, Tianxin; Ge, Xiaoyun; Zhao, Guiyu; Li, Yongguo; Zhang, Yi; Chen, Li |
| May-2020 | Efficacy and safety of DBPR108 monotherapy in patients with type 2 diabetes: a 12-week, randomized, double-blind, placebo-controlled, phase II clinical trial | Wang, Wei; Yao, Jun; Guo, Xiaohui; Guo, Yushan; Yan, Chaoli; Liu, Kuanzhi; Zhang, Ying; Wang, Xiaoyue; Li, Hongmei; Wen, Zhongyuan; Wang, Xinling; Li, Shuangqing; Xiao, Xinhua; Liu, Weijuan; Li, Ziling; Zhang, Lihui; Shao, Shiying; Ye, Handong; Qin, Guijun; Li, Yiming; Li, Feng; Zhang, Xiaomei; Li, Xuefeng; Peng, Yongde; Deng, Hongyan; Xu, Xiangjin; Zhou, Ligang; Huang, Yanli; Cao, Mengya; Xia, Xuefang; Shi, Mingbiao; Dou, Jing; Yuan, Jing |
| Feb-2020 | Efficacy of metformin in preventing progression to diabetes in a Chinese population with impaired glucose regulation: Protocol for a multicentre, open-label, randomized controlled clinical study | Ji, Linong; Sun, Ningling; Zhang, Yunliang; Zhang, Lihui; Shen, Sheng'ai; Wang, Xueying; Li, Qiuyun; Dong, Luling; Ren, Weidong; Qi, Lin; Li, Yufeng; Yan, Shuang; Cheng, Wenli; Kuang, Hongyu; Li, Guangwei |
| 2019 | Homocysteine causes vascular endothelial dysfunction by disrupting endoplasmic reticulum redox homeostasis | Wu, Xun; Zhang, Lihui; Miao, Yutong; Yang, Juan; Wang, Xian; Wang, Chih-chen; Feng, Juan; Wang, Lei |
| 2017 | Pharmacodynamic subgroup analysis of glucose kinase activator (GKA) after 12 weeks of treatment with HMS5552 in T2DM patients in China | Zhu, Dalong; Gan, Shenglian; Liu, Yu; Ma, Jianhua; Dong, Xiaolin; Song, Weihong; Zeng, Jiaoe; Wang, Guixia; Zhao, Wenjuan; Zhang, Qiu; Li, Yukun; Fang, Hui; Lv, Xiaofeng; Shi, Yongquan; Tian, Haoming; Ji, Linong; Gao, Xin; Zhang, Lihui; Bao, Yuqian; Lei, Minxiang; Li, Ling; Zeng, Longyi; Li, Xiaoying; Hu, Tianxin; Zhao, Guiyu; Ge, Xiaoyun; Zhao, Yu; Hou, Xinghua; Li, Yongguo; Zhang, Yi; Chen, Li |
| 2017 | Pharmacodynamic subgroup analysis of glucose kinase activator (GKA) after 12 weeks of treatment with HMS5552 in T2DM patients in China | Zhu, Dalong; Gan, Shenglian; Liu, Yu; Ma, Jianhua; Dong, Xiaolin; Song, Weihong; Zeng, Jiaoe; Wang, Guixia; Zhao, Wenjuan; Zhang, Qiu; Li, Yukun; Fang, Hui; Lv, Xiaofeng; Shi, Yongquan; Tian, Haoming; Ji, Linong; Gao, Xin; Zhang, Lihui; Bao, Yuqian; Lei, Minxiang; Li, Ling; Zeng, Longyi; Li, Xiaoying; Hu, Tianxin; Zhao, Guiyu; Ge, Xiaoyun; Zhao, Yu; Hou, Xinghua; Li, Yongguo; Zhang, Yi; Chen, Li |
| 14-Dec-2023 | A phase 2 randomised controlled trial of mazdutide in Chinese overweight adults or adults with obesity | Ji, Linong; Jiang, Hongwei; Cheng, Zhifeng; Qiu, Wei; Liao, Lin; Zhang, Yawei; Li, Xiaoli; Pang, Shuguang; Zhang, Lihui; Chen, Liming; Yang, Tao; Li, Yan; Qu, Shen; Wen, Jie; Gu, Jieyu; Deng, Huan; Wang, Yanqi; Li, Li; Han, Han-Zhang; Ma, Qingyang; Qian, Lei |
